Search details
1.
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms.
Pharmacogenet Genomics
; 34(4): 126-129, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38359166
2.
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms.
Support Care Cancer
; 30(10): 8059-8067, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35776183
3.
Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.
Oral Dis
; 28(1): 193-201, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-33274559
4.
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity.
Pharmacogenet Genomics
; 31(5): 116-123, 2021 07 01.
Article
in English
| MEDLINE | ID: mdl-34096894
5.
Correction to: Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
Breast Cancer Res Treat
; 180(3): 623, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32180072
6.
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
Breast Cancer Res Treat
; 180(3): 611-622, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32067153
7.
Genetic variation in EPHA contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Br J Clin Pharmacol
; 86(5): 880-890, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31823378
8.
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion.
Breast Cancer Res Treat
; 175(2): 297-303, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-30747308
9.
Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma.
Invest New Drugs
; 37(2): 323-330, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30393825
10.
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients.
Breast Cancer Res Treat
; 165(3): 659-668, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28643023
11.
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer.
Breast Cancer Res Treat
; 138(3): 807-16, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23546553
12.
Discovery of ERD-3111 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader with Strong Antitumor Activity.
J Med Chem
; 66(17): 12559-12585, 2023 09 14.
Article
in English
| MEDLINE | ID: mdl-37647546
13.
Effects of CYP3A4 and CYP2C9 genotype on systemic anastrozole and fulvestrant concentrations in SWOG S0226.
Pharmacogenomics
; 24(12): 665-673, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37615099
14.
Impact of Pharmacogenetics on Intravenous Tacrolimus Exposure and Conversions to Oral Therapy.
Transplant Cell Ther
; 28(1): 19.e1-19.e7, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34583027
15.
Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus.
Pharmgenomics Pers Med
; 14: 319-326, 2021.
Article
in English
| MEDLINE | ID: mdl-33746516
16.
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer.
Front Genet
; 12: 662734, 2021.
Article
in English
| MEDLINE | ID: mdl-34211496
17.
PD-L1 expression on circulating tumor cells and platelets in patients with metastatic breast cancer.
PLoS One
; 16(11): e0260124, 2021.
Article
in English
| MEDLINE | ID: mdl-34780566
18.
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Pharmacogenomics
; 21(12): 841-851, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32700628
19.
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers.
Clin Cancer Res
; 26(24): 6568-6580, 2020 12 15.
Article
in English
| MEDLINE | ID: mdl-32967938
20.
Impact of CYP3A5 phenotype on tacrolimus concentrations after sublingual and oral administration in lung transplant.
Pharmacogenomics
; 20(6): 421-432, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30983501